![]() |
||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
| Products | ||||||||||||||||||||||||||||||||
Bone Health Assessment (Osteo-Health) GeneLink’s Bone Health assessment looks for SNPs in several key genes associated with bone density and bone loss and is designed to help predict an individual's susceptibility to osteopenia – a condition that often leads to osteoporosis. Osteoporosis is responsible for 1.5 million fractures each year, most notably fractures of the vertebrae, forearms, wrists and hips (these are often crippling and sometimes fatal). According to the National Osteoporosis Foundation, one in three women and at least one in twelve men will develop osteoporosis during their lifetime. GeneLink's Bone Health assessment is an important predictive tool that can be used as a guide to help determine an individual's genetic propensity for bone density loss, and to help create a therapeutic strategy that minimizes in-born health risks. |
||||||||||||||||||||||||||||||||
|
|
© Copyright 2008, GeneLink BioSciences, Inc. All Rights Reserved. GeneLink is a Registered Trademark of © GeneLink BioSciences, Inc. |
||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||